0.015EUR
279.84 KEUR
15.24 M
About HERANTIS PHARMA OYJ
Sector
CEO
Antti Vuolanto
Headquarters
Espoo
Website
Employees (FY)
10
Founded
2008
ISIN
FI4000087861
FIGI
BBG006GWBH62
Herantis Pharma Oyj engages in the research and development of biopharmaceutical products. It offers medicinal products such as Cis-UCA eye drops for dry eye, CDNF for Parkinson's disease, Lymfactin for secondary lymphedema, Cis-UCA emulsion cream for atopic dermatitis, and CDNF for amyotrophic lateral sclerosis (ALS). The company was founded by Eero Hemminki Castren, Henri Juhani Huttunen, Heikki Rauvala, and Mart Saarma in 2008 and is headquartered in Espoo, Finland.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of HRTIS is 1.435 EUR — it has decreased by 1.03% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXHEX exchange HERANTIS PHARMA OYJ stocks are traded under the ticker HRTIS.
HERANTIS PHARMA OYJ is going to release the next earnings report on Aug 22, 2024. Keep track of upcoming events with our Earnings Calendar.
HRTIS stock is 5.28% volatile and has beta coefficient of −0.01. Check out the list of the most volatile stocks — is HERANTIS PHARMA OYJ there?
One year price forecast for HERANTIS PHARMA OYJ has a max estimate of 2.900 EUR and a min estimate of 2.900 EUR.
Yes, you can track HERANTIS PHARMA OYJ financials in yearly and quarterly reports right on TradingView.
HRTIS stock has risen by 0.70% compared to the previous week, the month change is a 0.70% rise, over the last year HERANTIS PHARMA OYJ has showed a 37.34% decrease.
HRTIS net income for the last quarter is 2.08 M EUR, while the quarter before that showed −1.80 M EUR of net income which accounts for 215.60% change. Track more HERANTIS PHARMA OYJ financial stats to get the full picture.
Today HERANTIS PHARMA OYJ has the market capitalization of 29.23 M, it has increased by 1.37% over the last week.
No, HRTIS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, HRTIS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HERANTIS PHARMA OYJ stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 10.00 employees. See our rating of the largest employees — is HERANTIS PHARMA OYJ on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HERANTIS PHARMA OYJ technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HERANTIS PHARMA OYJ stock shows the sell signal. See more of HERANTIS PHARMA OYJ technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on HERANTIS PHARMA OYJ future price: according to them, HRTIS price has a max estimate of 2.90 EUR and a min estimate of 2.90 EUR. Read a more detailed HERANTIS PHARMA OYJ forecast: see what analysts think of HERANTIS PHARMA OYJ and suggest that you do with its stocks.